Latest Conference Articles

In a session from the PDS 2021 Virtual Super-Conference, experts discussed how POC testing capabilities enhance patient services and address antimicrobial resistance.

A session from the 2021 PQA Annual Meeting highlighted the benefits of virtual outreach in advancing patient care amid the COVID-19 pandemic and beyond.

Individuals with prediabetes may be at increased risk of suffering an adverse cardiovascular event.

A session at the 2021 Pharmacy Quality Alliance Meeting explored the results of Walgreens’ recent initiatives focused on addressing social determinants of health.

The awards honor an individual and community pharmacy for innovative, pioneering practices.

A session held during the 2021 PQA Annual Meeting explored implications for shared decision-making interventions in value-based care.

A session held at the HOPA Annual Meeting 2021 discussed investigational cancer drugs in clinical trials.

Real-world data comparing erenumab with oral preventive medications was presented at the American Academy of Neurology’s 73rd Annual Meeting.

A session held at the HOPA Annual Meeting 2021 discussed best practices for optimizing opioid treatment in patients with cancer pain.

Research presented at the HOPA Annual Conference 2021 supported the benefit and feasibility of a pharmacy-led adherence and monitoring program for oral antineoplastic agents.

Findings presented at the Hematology/Oncology Pharmacists Association Annual Meeting 2021 discussed burnout and job dissatisfaction among oncology and hematology pharmacists.

At the HOPA Annual Conference 2021, Lakesha Butler, PharmD, BCCPS, discussed how pharmacists can disrupt the status quo to fight racism and work toward health equity for all.

Get the latest information on new treatments approved and marketed in the last year.

A session held during the American Pharmacists Association 2021 Annual Meeting and Exposition provided an update on diabetes practice changes and new treatments.

Survey results suggest independent pharmacies may be better positioned than chains to offer COVID-19 POC testing to their patients.

In a presentation from APhA2021, clinical pharmacist Danielle Fixon, PharmD, BCGP, BCPS, offers counseling tips for CBD products.

An update on COVID-19 advocacy activity and regulations affecting your pharmacy practice.

Research presented during the APhA 2021 Annual Meeting and Exposition examined the clinical use of ketamine as an abortive therapy for migraines and primary headaches.

Keynote speaker Dan Schneider, from the Netflix documentary “The Pharmacist,” discusses his story and mission to end the opioid epidemic.

Good Neighbor Pharmacy has announced that ThoughtSpot 2021 will be fully virtual this year.

Results of a study presented in a poster presentation during ASHP Midyear collected data of the available OTC CBD products being sold in Colorado pharmacies.

Pharmacists can provide education on migraine prophylaxis for better outcomes.

Several key regulatory changes made over the past year affect health-system pharmacists.

Our final episode in our ThoughtSpot 2020 podcast series features NPhA president Dr. Ryan Marable and immediate past president Dr. Lakesha Butler, who share insights on health disparities and the social determinants of health.

Survey results presented during the ASHP 2020 Midyear Clinical Meeting and Exhibition offered insight into community pharmacists’ knowledge and confidence of CBD products.

A poster presented at the ASHP 2020 Midyear Clinical Meeting and Exhibition indicated opportunities for community pharmacists to improve outcomes for patients with migraines.

In a session held during ASHP Midyear 2020 Clinical Meeting & Exhibition, Anthony Fauci, MD, warned pharmacists of challenging months ahead amid the COVID-19 pandemic.

Pharmacists can prepare themselves to address patients’ questions and concerns about the COVID-19 vaccines.